Darunavir-based dual therapy of treatment-experienced HIV-infected patients: analysis from a national multicenter database

Background We assessed the virological response of dual therapy with DRV/r, plus raltegravir, maraviroc or etravirine, in virological failure patients and in virologically suppressed patients collected in the Italian Antiretroviral Resistance Database (ARCA).